Global Giants Like Pfizer In Better Position To Tackle Counterfeiting
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Drug companies are stepping up efforts to fight counterfeit products that are emerging around the world as potential profits grow and penalties, compared to those associated with dealing in illegal narcotics, are relatively low
You may also be interested in...
IFPMA Outlines Plan For Fighting Counterfeit Drugs
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).